Welcome to our dedicated page for The Beauty Health Company news (Ticker: SKIN), a resource for investors and traders seeking the latest updates and insights on The Beauty Health Company stock.
The Beauty Health Company (SKIN), innovator of Hydrafacial systems and advanced aesthetic technologies since 1997, provides this centralized hub for investors and industry professionals. Our news collection offers immediate access to verified corporate developments, combining regulatory filings with market analysis for complete transparency.
This resource serves as your primary source for tracking earnings announcements, product innovations, and strategic partnerships that shape the medical aesthetics sector. Users benefit from chronological organization of press releases alongside third-party analyses, maintaining balanced perspectives on company milestones.
Content spans critical updates including FDA clearances, international expansion efforts, and clinical study results. Each entry is vetted for relevance to investor priorities and industry trends, with particular emphasis on the company's serum-based technology advancements.
Bookmark this page for real-time updates on SKIN's market movements and professional-grade insights into the $18B global aesthetics industry. Cross-reference our archive with SEC filings using provided document identifiers for complete due diligence capabilities.
BeautyHealth (NASDAQ: SKIN) reported Q4 2024 financial results, with net sales of $83.5 million, down 13.8% year-over-year, and full-year 2024 net sales of $334.3 million, declining 16.0% from 2023.
The company's active install base grew to 34,735 units from 31,446 in the prior year, driving growth in consumable sales. However, overall revenue decreased due to fewer unit placements, impacted by challenging macroeconomic conditions. Q4 gross margin improved to 62.7% from 47.2% in Q4 2023.
The company reported a Q4 net loss of $(10.3) million, relatively flat compared to $(9.4) million in Q4 2023. Adjusted EBITDA improved to $9.0 million from $3.4 million in Q4 2023, driven by lower operational spend and higher gross margins. Cash position stood at $370.1 million as of December 31, 2024.
BeautyHealth (NASDAQ: SKIN) has scheduled its fourth quarter and full year 2024 financial results announcement for March 12, 2025, after market close. The company, known for its flagship brand Hydrafacial, will host an investor conference call at 4:30 p.m. Eastern Time following the results release.
Interested parties can access the live webcast and supporting materials through BeautyHealth's investor relations website. A recording of the call will be made available approximately three hours after its conclusion.
BeautyHealth (NASDAQ: SKIN) has appointed Stephen J. Fanning to its Board of Directors, effective December 12, 2024. Fanning, a medical aesthetics veteran and former Hydrafacial Chairman (2016-2020), brings extensive industry experience to the role. His previous positions include President and CEO of Spectrum Solutions, leadership at Z-Medica, Solta Medical, and Johnson & Johnson. He currently serves as Chairman for Champion Manufacturing and LKC Technologies.
Fanning will join both the Nominating & Corporate Governance Committee and the Audit Committee, bringing the total board membership to eight directors. BeautyHealth Executive Chairman Brent Saunders highlighted Fanning's expertise in medical aesthetics and proven track record in driving global growth as valuable assets for the company's future growth and profitability initiatives.
BeautyHealth (NASDAQ: SKIN) has released its 2024 Skintuition Report, highlighting key trends in the beauty and skincare industry. The report reveals significant consumer shifts towards skinimalism and clinically proven treatments. Notable metrics include an 8% increase in Hydrafacial Perk Lip Treatments and a 55% surge in neck and décolleté treatments globally compared to the previous year.
The report identifies key trends for 2025, including the medicalization of beauty, rise of skintellectual consumers, skinimalism revival, focus on beautility, and tailored treatments. The company's Hydralock HA Booster, which triples hydration after one treatment, has become their most successful branded booster launch to date.
The Beauty Health Company (NASDAQ: SKIN) announced its Q3 2024 financial results, reporting net sales of $78.8 million, a decrease of 19.1% year-over-year. Gross margin improved to 51.6% from -12.9% in Q3 2023, driven by the absence of previous charges. Adjusted gross margin increased to 69.5%. Net loss narrowed to $18.3 million from $73.8 million in the prior year. Adjusted EBITDA was $8.1 million, down from $9.1 million in Q3 2023. The company sold 1,118 delivery systems, down from 2,140 units, reflecting a challenging macroeconomic environment. BeautyHealth revised its full-year net sales guidance to $322-$332 million and improved adjusted EBITDA guidance to -$2 to $4 million. Strategic moves included centralizing manufacturing in Long Beach and enhancing its commercial leadership.
The Beauty Health Company (NASDAQ: SKIN), known for its Hydrafacial™ brand, has scheduled its third quarter 2024 financial results announcement for Tuesday, November 12, 2024, after market close. The company will host an investor conference call at 4:30 p.m. Eastern Time following the results release. Investors can access the live webcast and supporting materials through the company's investor relations website, with a recording available approximately three hours after the call concludes.
The Beauty Health Company (NASDAQ:SKIN), known for its flagship brand Hydrafacial™, has announced a video poster abstract presentation at the upcoming American Society for Dermatologic Surgery (ASDS) meeting in Orlando, Florida from October 17-20, 2024. The presentation will focus on the efficacy and safety of Hydrafacial treatments combined with non-ablative fractional laser and intense pulsed light (IPL) full-face treatments.
CEO Marla Beck highlighted the significance of this presentation, stating that it will provide scientific validation for the complementary effects of Hydrafacial with other aesthetic treatments. The study, titled 'A Randomized, Split-face, Prospective, Study to Assess the Efficacy and Safety of Hydradermabrasion after 1927nm Non-ablative Fractional Laser or Intense Pulsed Light Full-Face Treatments', will be presented by Dr. Michael Abrouk. The abstract emphasizes the synergistic effects of Hydrafacial when combined with non-ablative laser and IPL treatments, showcasing its ability to enhance overall skin quality, hydration, and treatment outcomes.
The Beauty Health Company (NASDAQ:SKIN), known for its Hydrafacial brand, has announced two key appointments to its commercial leadership team, effective October 15, 2024. Ron Menezes will join as Chief Revenue Officer, replacing Dan Watson, while Carrie Caulkins will fill the open position of Chief Marketing Officer. Both will report to CEO Marla Beck.
Menezes, with over 20 years of experience in aesthetics and medical devices, will lead global sales, business development, and customer training. Caulkins, formerly of Galderma, will oversee global marketing initiatives for the Hydrafacial brand. These appointments aim to strengthen the company's senior leadership and drive sales and profit growth.
The Beauty Health Company (NASDAQ:SKIN), known for its Hydrafacial™ brand, has announced the Hydrafacial Glow Getter Scholarship program. This initiative aims to support aspiring and licensed estheticians in their career development within the growing field of esthetics, projected to expand 10% through 2033. In partnership with Beauty Changes Lives, the program will offer $60,000 in scholarships over two years, with applications opening on December 1, 2024.
The scholarships will provide financial tuition assistance for individuals enrolled in esthetics programs leading to licensure or certification in the US and Canada, as well as support educational advancement for currently licensed estheticians. This announcement coincides with National Esthetician Day on October 15, kicking off a week-long celebration of skin health professionals.
Hydrafacial has already trained over 40,000 estheticians globally through its HFX and HFX Business programs. In 2023, the company launched the School Partner Program, offering enhanced training curriculums and special pricing to participating esthetics schools and students.
The Beauty Health Company (NASDAQ:SKIN) has launched the Hydrafacial Hydralock HA Booster globally. This clinically proven formulation is designed to combat dehydrated, dull, and stressed skin. Key features include:
- Increases skin hydration by over 300%
- Reduces wrinkle appearance by 63% after one treatment
- Contains Triple Hyaluronic Acid Complex, Vitamin B5, and Fruit Extracts
- Delivers 24-hour moisture and glow
Clinical results show:
- 455% increase in hydration immediately after treatment
- 338% increase in hydration after 24 hours
- 57% reduction in wrinkle appearance immediately after treatment
- 63% reduction in wrinkle appearance after 24 hours
94% of participants reported more hydrated, moisturized, and brighter skin 48 hours post-treatment. The booster is now available in the UK.
